(Q43810622)

27 November 2017

title

The effect of Losartan on insulin resistance and beta cell function in chronic hemodialysis patients (English)

1 reference

27 November 2017

1 reference

1 reference

Fishman S

1

1 reference

27 November 2017

Rapoport MJ

2

1 reference

27 November 2017

Weissgarten J

3

1 reference

27 November 2017

Zaidenstein R

4

1 reference

27 November 2017

Dishi V

5

1 reference

27 November 2017

Hartzeanu I

6

1 reference

27 November 2017

Golik A

7

1 reference

27 November 2017

language of work or name

1 reference

1 September 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

23

1 reference

27 November 2017

issue

5

1 reference

27 November 2017

page(s)

685-692

1 reference

Effect of hemodialysis on peripheral glucose metabolism of patients with chronic renal failure.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Insulin resistance in uremia: effect of dialysis modality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Cardiovascular risk factors in chronic renal failure and hemodialysis populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Mechanism and clinical implication of insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Improvement of insulin sensitivity for glucose metabolism with the long-acting Ca-channel blocker amlodipine in essential hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Losartan mediated improvement in insulin action is mainly due to an increase in non-oxidative glucose metabolism and blood flow in insulin-resistant hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

Effects of losartan on insulin sensitivity in hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-100107365

21 January 2018

Identifiers

DOI

10.1081/JDI-100107365

1 reference

27 November 2017

1 reference